Use of aspirin for the primary prevention of cardiovascular disease is a controversial topic. Recent evidence, compounded by the ACC/AHA guidelines on primary prevention suggests that Aspirin risks of gastrointestinal bleeding outweigh the benefit of cardiovascular protection.

This presentation will cover second-line therapy options available for the treatment of type 2 diabetes. Attention will be given to the benefits and risks of those treatment options in the older adult population. Patient cases will be utilized to reinforce appropriateness in older adults.

This session targets a healthcare professional audience and will define the social determinants of health (SDOH) according to Healthy People 2030. The five key domain areas of SDOH and how they contribute to health disparities will also be explored.

This is a 1 hour C.A.R.E.S. CE article available for 1 CE credit. Instructions will be given within the course. Please click on the "Register" tab then the "Take Course" button.